Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase I/II study to evaluate the safety and preliminary activity of nivolumab in combination with vorolanib in patients with refractory thoracic tumors Whisenant, J. G., Beckerman, K., Borghaei, H., Owonikoko, T., Patel, J., Shyr, Y., Harrow, K., Liang, C., Holzhausen, A., Wakelee, H., Horn, L. AMER ASSOC CANCER RESEARCH. 2019
View details for DOI 10.1158/1538-7445.AM2019-CT171
View details for Web of Science ID 000488129900153